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Abstract
Background: We investigated lifetime alcohol consumption and prostate cancer risk in a case-
control study conducted in Buffalo, NY (1998–2001).
Methods: The study included 88 men, aged 45 to 85 years with incident, histologically-confirmed
prostate cancer and 272 controls. We conducted extensive in-person interviews regarding lifetime
alcohol consumption and other epidemiologic data.
Results: Prostate cancer risk was not associated with lifetime intake of total and beverage specific
ethanol. In addition we found no association with number of drinks per day (average drinks per day
over the lifetime) or drinks per drinking day (average drinks per day on drinking days only over the
lifetime). However, we observed an inverse association with the total number of drinking years.
Men in the lowest tertile of total drinking years had a two-fold prostate cancer risk than men in
the highest tertile (OR 2.16, 95% CI 0.98–4.78, p for trend <0.05).
Conclusion: Our results suggest that alcohol intake distribution across lifetime may play a more
important role in prostate cancer etiology than total lifetime consumption.
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Background
Prostate cancer is the most frequently diagnosed malig-
nancy and the second leading cause of cancer death
among men in the Western countries [1]. Notwithstand-
ing the importance of this malignancy, little is understood
about its cause. To date the only well established risk fac-
tors are age, family history of disease, race and country of
residence [2], while the body of the evidence about the
role of alcohol intake is still controversial. Since alcohol
consumption is a common lifestyle factor and potentially
modifiable, the finding of an association with prostate
cancer could have an important impact on public health.
Among the population-based case-control studies, those
carried out by Heyes et al. [3] and Sharpe et al. [4] found
an increased risk of prostate cancer associated with alco-
hol consumption. Risk increased with increasing fre-
quency of alcohol consumption [3] and among those
who drank regularly over a longer period [4]. Sesso et al.,
in their prospective cohort study, confirmed the finding of
a higher risk associated with alcohol consumption [5].
However, numerous studies published since 1998 have
not found an association between alcohol intake and
prostate cancer [6-17]. In a review by Breslow and Weed,
only 6 of 32 studies reported a positive association
between alcohol use and prostate cancer [18]; however,
they noted that many of the studies had biases that could
have attenuated the risk estimates.
Although prostate cancer is known to have a long latency
period, lifetime alcohol consumption was not addressed
in the studies carried out until the late 1990s, and rarely
in the more recent studies [18]. Furthermore, investigators
focusing on this topic have considered lifetime alcohol
consumption as the average total amount of alcohol con-
sumed over the lifetime, rarely taking into account such
characteristics as number of drinks consumed on a typical
drinking day or other descriptions of drinking pattern.
The distribution of an equivalent volume of alcohol
across multiple drinking occasions rather than a single
occasion (e.g., one drink per day vs. seven drinks on single
day) is likely to have different physiologic effects and
impact on cancer risk. Likewise, an examination of aver-
age total lifetime alcohol intake does not address the pos-
sibility that, although the total lifetime volume may not
differ, the duration of intake may, thus effectively result-
ing in a higher dose over a shorter time period.
Alcohol may act as a carcinogen itself and may also mod-
ulate risk from other carcinogen exposures. It has been
implicated in risk of cancer at a number of sites [19,20].
In the present case-control study we examined the associ-
ation between lifetime alcohol intake, duration of alcohol
use, and drinks per day with risk of prostate cancer in
western New York.
Methods
We conducted a case-control study of prostate cancer and
hormones and alcohol intake (the PROMEN STUDY) in
Erie and Niagara Counties, NY, USA, between December
1998 and April 2001. The methods for this study have
been previously described in detail [21]. Participants pro-
vided informed consent; the Institutional Review Board of
the University at Buffalo, School of Medicine and Bio-
medical Science, and each of the participating hospitals
approved the procedures for the protection of human sub-
jects recruited for the study.
Cases were men aged 45 to 85 years with incident, pri-
mary, histologically confirmed prostate cancer. Men with
a previous history of cancer (except non-melanoma skin
cancer), or already on hormonal or chemotherapy treat-
ment (current or in the 6 months prior to diagnosis), as
well as those affected by chronic or acute liver diseases,
were excluded. Cases aged 35–65 years were also required
to have a driver's license, because we used driver's license
records to identify age matched controls.
During the study period, 504 men were identified with
incident prostate cancer. Of these, 336 men did not meet
the eligibility criteria; we invited the remaining 163
patients to participate in the PROMEN study. After being
contacted, 50 men refused to participate resulting in a par-
ticipation rate of 70%. Ninety-six patients had complete
data for the variables of interest.
Controls aged between 35 and 65 years were selected from
a list of individuals holding a New York State driver's
license and residing in Erie and Niagara Counties. Those
aged 65 and over were selected from the rolls of the
Health Care Financial Administration. As with cases, men
on hormonal treatment (current or in the 6 months prior
the diagnosis), or diagnosed with metabolic or endocrine
disease were excluded, as well as participants with a previ-
ous story of cancer other than non-melanoma skin cancer.
Since it is well known that latent prostatic carcinoma has
a high prevalence in men over 50 [22,23], we evaluated
prostate specific antigen (PSA) in the blood samples
obtained from controls. Controls found to have a PSA
value higher than 4 ng/ml were excluded from the control
group, in accordance with the criterion established by the
American Cancer Society Prostate Cancer Detection
Project [24] until the completion of further diagnostic
procedures to clarify their true case-control status.
During the study period, 1373 potential controls were
contacted. One hundred and seventy nine of these indi-
viduals were deceased or were too ill to participate, 293
did not meet the eligibility criteria and we were not able
to contact 272 persons. We identified eight prostate can-
cer cases as a result of PSA determination in subjects whoNutrition Journal 2004, 3:23 http://www.nutritionj.com/content/3/1/23
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initially were recruited as controls. Three hundred and
seventeen of the remaining 513 subjects (60%) were
enrolled and interviewed: 304 had complete data for
analysis.
Extensive data on demographics, smoking history, alco-
hol consumption, and other study variables were col-
lected by trained interviewers during in-person computer-
assisted interviews [25] and with self-administered ques-
tionnaires. Height, weight, waist and hip circumferences
were measured by trained technicians using a standard-
ized protocol. Body mass index (BMI) was calculated as
weight in kilograms divided by square of the height in
meters (kg/m2). Waist to hip ratio (WHR) was calculated
as waist circumference divided by hip circumference.
Alcohol intake
Detailed information on alcohol consumption through-
out the lifetime was collected using the Cognitive Lifetime
Drinking History [26,27]. Prior to the interview, partici-
pants completed a lifetime events calendar on which they
recorded the date and their age when significant events in
their life occurred. The calendar was used during the inter-
view to help them remember what they were doing during
specified periods of their lives and whether drinking alco-
hol was involved. Participants reported the age when they
started drinking alcohol regularly (at least once a month
for six months) and when their drinking changed over the
years. When changes were reported, participants were
asked whether they continued regular drinking; if not,
they were asked if they ever resumed regular drinking.
Using this information, we defined intervals during each
participant's life when drinking patterns were relatively
homogeneous and computed the total number of drink-
ing years and the total number of abstinent years. Lists of
alcoholic beverages, beer, wine, wine coolers, and liquor,
and models of glasses and bottles were used to help
respondents recall what beverages they drank over their
lifetimes; their usual drink size of each beverage; and
whether drink size changed over their lifetimes. This pro-
vides information used to: (1) calculate absolute alcohol
intakes and (2) tailor the computer-assisted interview to
the each respondent's drinking history. Patterns of drink-
ing were ascertained for intervals during which respond-
ents drank weekly or more often by asking how often
respondents drank on Fridays, Saturdays, Sundays, and
weekdays, and how many drinks they usually had on
each. For intervals during which respondents drank less
often than weekly, they were asked standard quantity and
frequency questions. Quantity and frequency for times
when they drank more than usual were assessed for all
intervals, as was the frequency of intoxication; the propor-
tion of drinks they had with meals/snack/without eating;
and the proportion of drinks from beer, wine, wine cool-
ers, and liquor.
Drinks per interval was estimated by multiplying quantity
by frequency for days of the week and more than usual
and adding. Drinks per interval was translated into ounces
of ethanol per interval based on the proportion of drinks
represented by specific beverages, respondents' beverage-
specific drink size in ounces, and factors representing the
average percent per ounce of absolute alcohol for a given
beverage to estimates of drinks per interval. Factors used
were 0.048, 0.12, 0.04 and 0.40, for beer, wine, wine
cooler and hard liquor, respectively. These estimates were
summed across drinking intervals to yield lifetime totals.
We considered several variables in these analyses: total
number of years alcohol was consumed, number of drinks
per day during the drinking years (total number of drinks/
total number of days in drinking years), number of drinks
per drinking day (total number of drinks/total number of
days on which alcohol was consumed in drinking years),
total lifetime ounces of ethanol and beverage-specific
total lifetime ounces of ethanol. Because few participants
consumed wine coolers, wine and wine coolers were com-
bined. A drink was defined as 12 ounces of beer, 5 ounces
of wine, and 1.5 ounces of liquor.
Statistical analysis
Statistical analyses were conducted using SPSS for Win-
dows version 11.0. Differences between cases and con-
trols in demographic characteristics and alcohol
consumption were assessed using t-tests for continuous
variables and χ2 for categorical variables. Lifetime abstain-
ers, defined as those subjects who had less than 12 drinks
in any one year over their lifetimes, were excluded from
our analyses. The biological and social differences
between lifetime abstainers and both former and current
drinkers [28,29] and the very low number of these sub-
jects in our sample (5 cases and 11 controls) represent the
reasons for their exclusion from our analyses. Our final
sample size for analysis included 88 cases and 272
controls.
In analyses of risk associated with lifetime alcohol intake,
tertiles of total and beverage specific ounces and total
drinking years were computed based on the distribution
in the controls. For the beverage specific analyses, non-
drinkers were those respondents not consuming that par-
ticular alcoholic beverage. For risk associated with drinks
per day and drinks per drinking day, we categorized con-
sumption as two drinks or less per day and greater than
two drinks per day. Odds ratios (OR) and 95% confidence
intervals (CI) for risk of prostate cancer associated with
alcohol consumption were computed using uncondi-
tional logistic regression adjusting for age, cigarette smok-
ing status, education, body mass index (BMI), and waist
to hip ratio (WHRATIO). The beverage specific analyses
were further mutually adjusted for the other beverages.Nutrition Journal 2004, 3:23 http://www.nutritionj.com/content/3/1/23
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Results
Characteristics of the participants in the PROMEN study
are shown in Table 1. Compared to cases, controls were
slightly more educated (13.0 vs. 12.3 years) and more
likely to be Caucasian (93.0% vs. 67%). No statistically
significant differences between cases and controls were
observed for age, body mass index, waist to hip ratio,
smoking or drinking status.
Means and standard deviations for aspects of lifetime
alcohol consumption for the sample overall and by cur-
rent drinking status are shown in Table 2. Among drinkers
Table 1: Characteristics of prostate cancer cases and controls, PROMEN Study
Cases (n = 88) Controls (n = 272)
Mean (SDa)
Age, years 69.3 (8.4) 70.0 (6.3)
Education, years 12.3 (2.7)b 13.0 (2.8)
Body mass index, kg/m2 29.2 (5.2) 28.6 (4.6)
Waist to hip ratio
Percent
Race
White 67.0c 93.4
Non white 33.0 6.6
Smoking statusd
Never 23.8 28.3
Former 61.4 61.8
Current 14.8 9.9
Drinking statuse
Non-current drinkers 36.4 23.5
Current drinkers 63.6 76.5
astandard deviation; b p < 0.05, t-tests for differences in means between cases and controls; c p < 0.001, χ2 for differences in categorical variables 
between cases and controls; dsmoking status at the time of diagnosis in cases or interview in controls; edrinking status in the 12–24 months prior to 
diagnosis or interview, non-current drinkers stopped drinking at least 12–24 months prior to interview
Table 2: Selected lifetime alcohol consumption characteristics among prostate cancer cases and controls, PROMEN study
All drinkers 
(n = 360)
Former drinkers 
(n = 96)
Current drinkers 
(n = 264)
Cases 
(n = 88)
Controls 
(n = 272)
Cases 
(n = 32)
Controls 
(n = 64)
Cases 
(n = 56)
Controls
(n = 208)
Mean (SD) Mean (SD) Mean (SD)
Total drinking years 38.2 a (16.5) 43.7 (14.9) 32.9 (18.5) 33.8 (17.2) 41.3 a (14.5) 46.8 (12.7)
Total abstaining years 11.4 a (15.0) 6.6 (12.5) 19.8 (16.4) 18.2 (15.3) 6.6a (11.9) 3.0 (8.8)
Drinks per day 2.6 (7.3) 1.6 (3.4) 4.7 (11.6) 2.5 (5.8) 1.3 (1.7) 1.3 (2.2)
Drinks per drinking 
day
4.5 (7.3) 3.6 (4.3) 6.8 (11.3) 5.0 (6.3) 3.2 (2.5) 3.2 (3.4)
Total lifetime ethanol, 
ounces
12904.7 (18681.0) 11735.3 (12904.7) 19051.0 (26382.6) 13498.8 (21019.7) 9392.6 (11187.8) 11192.7 (16880.9)
Total lifetime ethanol 
from beer, ounces
6282.5 (11321.0) 6024.3 (9250.0) 7771.0 (15173.8) 5992.6 (12284.7) 5431.9 (8422.3) 6034.1 (8129.3)
Total lifetime ethanol 
from liquor, ounces
5654.2 (14571.6) 4067.2 (12815.8) 10307.0 (22051.6) 5233.7 (11480.5) 2995.5 (6480.2) 3708.3 (13204.5)
Total lifetime ethanol 
from wine/wine 
coolers, ounces
953.1 (2715.6) 1634.6 (4168.8) 958.9 (3588.4) 2271.0 (6154.0) 949.8 (2099.5) 1438.8 (3326.0)
a p < 0.05, t-tests for differences in means between cases and controlsNutrition Journal 2004, 3:23 http://www.nutritionj.com/content/3/1/23
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overall and current drinkers, cases drank for fewer years
than did controls (38.2 vs. 43.7 years, p < 0.05 and 41.3
vs. 46.8 years, p < 0.05, overall and current drinkers,
respectively) and, consequently, had greater numbers of
years abstaining. Few differences in lifetime total and bev-
erage-specific ounces consumed, drinks per day, or drinks
per drinking day were observed between cases and con-
trols for drinkers overall or current drinkers. However,
although not statistically significant, we observed several
differences in alcohol consumption between cases and
controls who were former drinkers. Among former drink-
ers, cases consumed more total ethanol, beer and liquor,
more drinks per day and more drinks per drinking day,
but consumed less ethanol from wine and wine coolers
compared to controls.
Odds ratios and 95% confidence intervals for the risk of
prostate cancer associated with lifetime alcohol consump-
tion are shown in Table 3. We observed no associations
with risk with lifetime ounces of total ethanol, beer, wine,
or liquor. Risk associated with total drinking years, years
of abstaining (ever/never), drinking status, drinks per day,
and drinks per drinking day are shown in Table 4. Com-
pared to the highest tertile of total drinking years, men in
the lowest tertile had a marginally significant increased
risk (OR 2.16, 95% CI 0.98–4.78, p for trend <0.05) and,
similarly, men reporting ever abstaining compared to
those who never abstained had increased prostate cancer
risk (OR 1.79, 95% CI 1.05–3.03). No associations with
risk were observed for former vs. current drinkers, drinks
per day, or drinks per drinking day.
Discussion
The assessment of lifetime alcohol consumption in cancer
etiology has been predominantly expressed through the
calculation of either total lifetime volume or an average
volume per specified time period across the lifetime. Few
investigations have evaluated lifetime drinking patterns in
relation to prostate cancer risk. While methodological dif-
ficulties challenge the evaluation of drinking patterns, our
results suggest that failure to take into account aspects of
drinking pattern such as the relative duration and dose of
consumption may reduce our ability to clearly elucidate
the role alcohol may be playing in cancer development.
Although we observed no associations with risk for total
lifetime alcohol intake or when alcohol was expressed as
average drinks per day or even average drinks per drinking
day, our results suggest that the impact may differ when
the same volume of alcohol consumption takes place in
fewer drinking years over a lifetime.
Furthermore, it is notable that alcohol consumption was
much higher among the cases compared with controls
who were former drinkers. As alcohol consumption has
been positively related to many causes of morbidity, a
proportion of these men may have stopped drinking in
response to poor health. Whether pre-existing morbid
conditions or heavier drinking is related to subsequent
development of prostate cancer remains to be clarified.
Our study has several strengths and limitations. A limita-
tion of our study is the small sample size, especially for
cases. However, because one of the original aims of the
Table 3: Odds ratios (OR)a and 95% confidence intervals (CI) for risk of prostate cancer associated with lifetime alcohol consumption
Cases (n = 88) Controls (n = 272) Odds Ratios (95% CI)
Total lifetime ethanol, ounces
≤2647.62 29 90 1.00
2647.62 – 11048.28 34 90 1.20 (0.65–2.23)
>11048.28 25 92 0.83 (0.43–1.60)
Total lifetime ethanol from beer, ouncesb
≤1941.78 42 120 1.00
1941.78 – 6237.30 25 75 1.16 (0.62–2.16)
>6237.30 21 77 0.89 (0.46–1.72)
Total lifetime ethanol from liquor, ouncesb
≤932.23 51 152 1.00
932.23 – 3976.79 15 59 0.71 (0.35–1.44)
>3976.79 22 61 0.91 (0.47–1.76)
Total lifetime ethanol from wine and wine cooler, ounces b
≤511.66 67 177 1.00
511.66 – 2283.00 10 47 0.76 (0.35–1.65)
>2283.00 11 48 0.60 (0.27–1.30)
a Adjusted for race, age (years), smoke, education (years), BMI, WHRATIO; bfurther mutually adjusted for other beveragesNutrition Journal 2004, 3:23 http://www.nutritionj.com/content/3/1/23
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study was an examination of hormones and prostate can-
cer, both cases and controls were carefully identified. To
eliminate the effect on hormone levels by treatment, cases
were enrolled in the study prior to starting chemotherapy
or hormone therapy; thus increasing the difficulty of case
ascertainment. On the other hand, the exclusion of con-
trols with high circulating PSA levels helped to reduce
misclassification and to ensure that the control group was
free from prostate cancer. The data used in the present
analysis were collected as a part of an in-person interview,
and the questionnaire about lifetime alcohol consump-
tion was very detailed allowing us to compute both the
dose and frequency aspects of alcohol consumption.
Given the difficulties involved in measuring alcohol con-
sumption, studies utilizing data collected before diagnosis
would appear more likely to lead to valid inferences.
Recently, Dennis in his meta-analysis [30] pointed out
that in many of the published cohort studies alcohol con-
sumption was assessed only at a baseline, often many
years before the diagnosis, with no subsequent assessment
to quantify changes in drinking pattern. While retrospec-
tive assessment of lifelong alcohol consumption at diag-
nosis may appear to be more likely to lead to recall bias,
such an assessment may also be more likely to capture rel-
evant attributes of exposure, such as overall duration of
alcohol use and timing of potentially important changes
in use, such as quitting. These differences are not always
taken into account [30].
The plausibility of alcohol as a risk factor for prostate can-
cer relates to evidence that alcohol may act as a carcinogen
or may modulate risk from other known carcinogens
through generation of free radicals, affecting the metabo-
lism of detoxification enzymes, impairment of immune
system and depression of DNA repair enzymes [31]. It
remains unclear to what extent alcohol could affect the
early phases of cancer development. Some studies suggest
that the critical period of exposure may be as early as ado-
lescence as the development of prostate gland begins pre-
natally, continuing until the end of puberty [31]. If
alcohol contributes to cancer promotion, duration and
relative intensity of exposure during a specified period of
time, instead of the total amount of the agent itself over
the entire life time course may be important.
Conclusions
Further studies focusing on lifetime exposure and more
specifically on patterns of consumption may help in pre-
vention of a disease with considerable public health
impact.
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